SCHEMBL20437400

SCHEMBL20437400

CC1(C)c2ccccc2N(c2cc(C#N)c(-c3c(C#N)cc(N4c5ccccc5C(C)(C)c5ccccc54)cc3N3c4ccccc4C(C)(C)c4ccccc43)c(N3c4ccccc4C(C)(C)c4ccccc43)c2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.36
KMT2A Q03164 5/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 1/20 0.35
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
MEN1 O00255 4/20 0.35
HTT P42858 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
MAPT P10636 1/20 0.35
KDM4E B2RXH2 1/20 0.33
LMNA P02545 2/20 0.32
AR P10275 2/20 0.32
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19340280 0.93 PGR (0.39) PGRKMT2ACYP1A2CYP2D6ITGB2
SCHEMBL20437395 0.90 AR (0.32) PGRKMT2ACYP1A2CYP2D6ITGB2
SCHEMBL20437402 0.82 PGR (0.39) PGRKMT2ACYP1A2CYP2D6ITGB2
SCHEMBL19345274 0.81 PGR (0.43) PGRKMT2ACYP1A2CYP2D6MEN1
SCHEMBL20437409 0.79 KDM4E (0.34) KMT2ACYP1A2MEN1MAPTKDM4E
SCHEMBL19344953 0.79 PGR (0.43) PGRKMT2ACYP1A2CYP2D6ITGB2
SCHEMBL13231494 0.79 PGR (0.43) PGRKMT2ACYP1A2CYP2D6ITGB2
SCHEMBL17955009 0.79 PGR (0.44) PGRKMT2AMEN1HTTCRHBP
SCHEMBL19344994 0.78 PGR (0.43) PGRKMT2AMEN1HTTCRHBP
SCHEMBL20437423 0.78 HDAC6 (0.39) PGRKMT2ACYP1A2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215711-A1 DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215711-A1 DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, AOX1, AOC2 PGR 4149/4885KMT2A 3423/4885CYP1A2 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.